Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • JAMA Original Investigation
    April 22, 2024

    Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments

    Joshua D.听Wallach,聽PhD, MS; Samuel聽Yoon,聽BS, BA; Harry聽Doernberg,聽MM; Laura R.听Glick,聽MD; Oriana聽Ciani,聽PhD; Rod S.听Taylor,聽PhD; Maryam聽Mooghali,聽MD; Reshma聽Ramachandran,聽MD, MHS, MPP; Joseph S.听Ross,聽MD, MHS
    Abstract Full Text
    online first
    JAMA. 2024; 10.1001/jama.2024.4175

    This study examines the strength of association between surrogate markers used as primary end points in clinical trials to support FDA approval of drugs treating nononcologic chronic diseases and clinical outcomes.

  • JAMA JAMA Clinical Guidelines Synopsis
    August 27, 2020

    Ulcerative Colitis in Adults

    Laura R.听Glick,聽MD; Adam S.听Cifu,聽MD; Lauren聽Feld,聽MD
    Abstract Full Text
    JAMA. 2020; 324(12):1205-1206. 10.1001/jama.2020.11583

    This JAMA Clinical Guidelines Synopsis summarizes the American College of Gastroenterology鈥檚 2019 guideline on ulcerative colitis in adults.

  • JAMA JAMA Clinical Guidelines Synopsis
    April 10, 2019

    Diagnosis and Management of Crohn Disease

    尝补耻谤别苍听贵别濒诲,听惭顿; Laura R.听Glick,聽BA; Adam S.听Cifu,聽MD
    Abstract Full Text
    JAMA. 2019; 321(18):1822-1823. 10.1001/jama.2019.3684

    This JAMA Clinical Guidelines Synopsis summarizes the 2018 American College of Gastroenterology (ACG) guideline on management of Crohn disease in adults.